1Assicot M, Gendrel D, Carsin H, et aL High serum procalcitonin concentrations in patients with sepsis and infection[J]. Lancet, 1993,341 (8844) :515-518.
2Gilbert DN. Use of plasma procalcitonin levels as an adjunct to clinical microbiology[J].J Clin Microbiol, 2010, 48 ( 7 ) : 2325-2329.
3Christ-Crain M, Muller B. Biomarkers in respiratory tract infections: diagnostic guides to antihiotic prescription, prognostic markers and mediators[J]. Eur RespirJ ,2007 ,30( 3) :556-573.
4Morgenthaler NG, StruckJ, Fischer-Schulz C, et aL Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA[J]. Clin Lab, 2002,48(5.fi) :263- 270.
5Choi HI. Procalcitonin in diagnosis of post-operative bacterial meningitis: a promising but limited role[J]. Infect Chemother, 2013,45(3) :346-348.
6Reinhart K, Bauer M, Riedemann NC, et al. New approaches to sepsis: molecular diagnostics and biomarkers[J] . Clin Microbiol Rev ,2012,25 (4) :609-634.
7Barati M, Alinejad F, Bahar MA, et al. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cares[J]. Burns ,2008 ,34( 6) : 770-774.
8Taskin E, Turgut M, Kilic M, et aL Serum procalcitonin and cerebrospinal fluid cytokines level in children with meningitis[J]. Mediators Inflamm ,2004,13 (4) :269-273.
10Viallon A, Guyomarc ' h P, Guyomarc ' h S, et al. Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis[J]. Crit Care,200S, 9(4) :R344-R3S0.
3Whang KT, Vath SD, Becker KL, et al. Procalcitonin and pro-inflammatory cytokine interactions in sepsis [ J]. Shock,2000,14(1): 73-78.
4Nijsten MW, Olinga P, The TH,et al. Procalcitonin behaves as a fastresponding acute phase protein in vivo and in vitro [ J]. Crit Care Med, 2000, 28 (2): 458461.
5Wiedermann FJ,Kaneider N,Egger P, et al. Migration of human monocytes in response to procalcitonin [J]. Crit Care Med, 2002 , 30(5): 1112-1117.
6Hoffmann G, Totzke G, Seibel M, et al. In vitro modulation of inducible nitric oxide synthase gene expression and nitric oxide synthesis by procalcitonin [J]. Crit Care Med, 2001, 29 (1): 112-126.
7Morgenthaler NG, Struck J, Chancerelle Y,et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection [J]. Horm Metab Res, 2003 , 35 ( 5): 290-295.
8Meisner M, Tschaikowsky K, Schnabel S, et al. Procalcitonin- influence of temperature,storage,anticoagulation and arterial or venous asservation of blood samples on procalcitonin concentrations [J]. EurJ Clin Chem Clin Biochem, 1997 , 35 ( 8): 597-601.
9Huang DT, Weissfeld LA, Kellum JA, et al. Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia [J]. Ann Emerg Med, 2008 , 52 (1): 48-58.
10Kruger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes [J]. Eur Respir J,2008,31 (2): 349-355.
